Latest Regulatory News

Orbital Corporation Ltd reports a stronger cash position and a strategic new order for its 350cc heavy fuel engine, signalling growth in both military and commercial UAV markets.

Klevo Rewards Limited has responded to ASX inquiries about a recent spike in its share price and trading volume, attributing the movement to a positive quarterly report and confirming full compliance with disclosure rules.

Lumos Diagnostics reported a strong surge in FebriDx® sales alongside positive FDA feedback, securing full Medicare reimbursement and advancing key clinical studies.

Wrkr Ltd has transitioned from development to deployment, launching key products and acquiring PaidRight to expand its payroll compliance offerings ahead of new legislation.

Paterson Resources has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information exists. The company points to imminent drilling results from its Grace Project as the likely catalyst for market activity.

Aeris Environmental Ltd has reported strong commercial momentum with its Syncromesh IoT platform and specialty chemicals, highlighted by initial orders from Budweiser APAC and a growing purchase order pipeline exceeding $800,000.

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.

Brightstar Resources has released an updated feasibility study for its Goldfields Project, projecting $1 billion in pre-tax free cash flow and a 74% internal rate of return, setting the stage for a Final Investment Decision in March 2026.

Cue Energy Resources reports steady production and a strong cash position, advancing long-term gas contracts in Australia with new drilling planned. Key developments in Indonesia and New Zealand also shape the company’s near-term outlook.

Anson Resources has kicked off a revised drilling program targeting lithium brines in Utah and secured a $14 million capital raise, alongside a key offtake agreement for its Green River Lithium Project.

Prominence Energy has completed its acquisition of the Gawler Natural Hydrogen Project, gaining a significant foothold in Australia's emerging natural hydrogen and helium sector. The company is advancing technical evaluations and preparing for early 2026 field surveys to validate its promising geological prospects.

InhaleRx Limited has progressed its clinical trials for three drug candidates targeting cancer pain, panic disorder, and treatment-resistant depression, while securing additional funding and preparing for a company rebrand.